Phase 2b/3 study of SP-624 in major depressive disorder
Latest Information Update: 26 Jan 2025
Price :
$35 *
At a glance
- Drugs SP 624 (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 26 Jan 2025 New trial record
Latest Information Update: 26 Jan 2025